ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Xtrackers MSCI Emerging Markets Climate Selection ETF

Xtrackers MSCI Emerging Markets Climate Selection ETF (EMCS)

27.0552
0.2799
(1.05%)
Closed January 25 3:00PM
27.13
0.0748
(0.28%)
After Hours: 6:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
27.0552
Bid
-
Ask
-
Volume
3,185
26.945 Day's Range 27.13
24.68 52 Week Range 28.4399
Previous Close
26.7753
Open
27.08
Last Trade
100
@
27.0552
Last Trade Time
Average Volume (3m)
463,328
Financial Volume
US$ 85,939
VWAP
26.9823

EMCS Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.58022.1915014164326.47527.1326.4254133424226.75495993SP
40.53532.018484232626.519927.1325.3450173726.1914847SP
12-0.9948-3.5465240641728.0528.439924.6846332826.50737455SP
26-0.9948-3.5465240641728.0528.439924.6846332826.50737455SP
52-0.9948-3.5465240641728.0528.439924.6846332826.50737455SP
156-0.9948-3.5465240641728.0528.439924.6846332826.50737455SP
260-0.9948-3.5465240641728.0528.439924.6846332826.50737455SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DIAMStar Diamond Corporation
$ 0.04
(33.33%)
851.62k
RAY.BStingray Group Inc
$ 7.95
(20.64%)
3k
EDTSpectral Medical Inc
$ 0.59
(15.69%)
68.5k
FRXFennec Pharmaceuticals Inc
$ 9.00
(13.92%)
8.33k
YRBYorbeau Resources Inc
$ 0.045
(12.50%)
1.44M
GLOGlobal Atomic Corporation
$ 0.63
(-32.98%)
14.4M
APLIAppili Therapeutics Inc
$ 0.03
(-14.29%)
108k
KRNKarnalyte Resources Inc
$ 0.12
(-14.29%)
4.07k
XAMXanadu Mines Ltd
$ 0.045
(-10.00%)
12.02k
AVCNAvicanna Inc
$ 0.28
(-9.68%)
303.69k
GLOGlobal Atomic Corporation
$ 0.63
(-32.98%)
14.4M
BMOBank of Montreal
$ 144.87
(0.61%)
7.29M
ENBEnbridge Inc
$ 64.61
(0.19%)
7.26M
TDToronto Dominion Bank
$ 82.18
(-0.06%)
5.9M
BCEBCE Inc
$ 33.77
(1.17%)
5.26M

Discussion

View Full Feed
oldmystic oldmystic 3 minutes ago
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 3 minutes ago
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 3 minutes ago
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 3 minutes ago
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 4 minutes ago
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 4 minutes ago
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 4 minutes ago
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 5 minutes ago
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 5 minutes ago
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 6 minutes ago
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 6 minutes ago
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 6 minutes ago
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 10 minutes ago
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 10 minutes ago
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 11 minutes ago
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 12 minutes ago
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 12 minutes ago
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 14 minutes ago
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL

Your Recent History

Delayed Upgrade Clock